Basheer I. Waziri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Basheer I. Waziri has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Hamisu Mohammed Salihu
Department of Epidemiology and Population Health, Kano Independent Research Centre Trust (KIRCT), Nigeria
3 shared publications - Aisha A. Abdullahi
Kano Independent Research Centre Trust
2 shared publications - Muhammad Adamu Abbas
Kano State Center for Disease Control and Prevention, Kano, Nigeria; Department of Community Medicine, Bayero University Kano, Nigeria
2 shared publications - Nasiru Abdullahi
Department of Biochemistry, Faculty of Basic Medical Sciences, Bayero University Kano, Kano, 700006, Nigeria
2 shared publications Ahmad Abdulhadi
Department of Microbiology, Division of Tuberculosis and Antimicrobial Resistance Research, Kano Independent Research Center Trust, Nigeria
1 shared publication- Ahmad Abdulhadi
Kano Independent Research Centre Trust
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by AOSIS in African Journal of Laboratory Medicine
- Vol. 15 (1) , 13
Systematic review on genomic insights into antimicrobial resistance in ESKAPE pathogens
Background: Antimicrobial resistance (AMR) is a major global public health threat. ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) pose a major threat owing to resistance to last-line antibiotics. Genomic surveillance is crucial to understanding global and regional antimicrobial resistance genes (ARGs) in AMR transmission. Aim: This systematic review synthesised global genomic evidence to identify global and region-specific ARGs distribution among ESKAPE pathogens. Methods: Following PRISMA guidelines, studies published January 2019 to December 2024 were identified from PubMed, Google Scholar, and Web of Science. Eligible studies reported genomic characteristics and resistance patterns of one or more ESKAPE pathogens from any source. Results: Seventy-seven studies were included, with most originating from Asia, followed by Europe and Africa. Clinical isolates predominated K. pneumoniae was the most frequently investigated pathogen, followed by S. aureus, P. aeruginosa, and A. baumannii. The most reported resistance genes were blaCTX-M, blaNDM, and blaSHV. Distinct regional patterns of antimicrobial resistance gene (ARG) distribution were observed, with tetracycline and quinolone resistance genes prevailing in Africa and South America, and blaOXA variants dominating in Asia and Europe. Region-specific ARG patterns were identified through descriptive synthesis and comparative analysis of study-reported frequencies. Conclusion: This review provides a synthesised global map of ARG distribution in ESKAPE pathogens, highlighting surveillance gaps in underrepresented regions and non-clinical settings. Addressing these gaps will support targeted genomic surveillance and stewardship programmes. What this study adds: This study contributes to the body of knowledge by mapping global and regional antimicrobial resistance gene patterns in ESKAPE pathogens, identifying key surveillance gaps and informing targeted AMR monitoring and stewardship strategies.
- 1 January 2026
- Published by AOSIS in African Journal of Laboratory Medicine
- Vol. 15 (1) , 13
Open AccessSystematic review on genomic insights into antimicrobial resistance in ESKAPE pathogens
Background: Antimicrobial resistance (AMR) is a major global public health threat. ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) pose a major threat owing to resistance to last-line antibiotics. Genomic surveillance is crucial to understanding global and regional antimicrobial resistance genes (ARGs) in AMR transmission. Aim: This systematic review synthesised global genomic evidence to identify global and region-specific ARGs distribution among ESKAPE pathogens. Methods: Following PRISMA guidelines, studies published January 2019 to December 2024 were identified from PubMed, Google Scholar, and Web of Science. Eligible studies reported genomic characteristics and resistance patterns of one or more ESKAPE pathogens from any source. Results: Seventy-seven studies were included, with most originating from Asia, followed by Europe and Africa. Clinical isolates predominated K. pneumoniae was the most frequently investigated pathogen, followed by S. aureus, P. aeruginosa, and A. baumannii. The most reported resistance genes were blaCTX-M, blaNDM, and blaSHV. Distinct regional patterns of antimicrobial resistance gene (ARG) distribution were observed, with tetracycline and quinolone resistance genes prevailing in Africa and South America, and blaOXA variants dominating in Asia and Europe. Region-specific ARG patterns were identified through descriptive synthesis and comparative analysis of study-reported frequencies. Conclusion: This review provides a synthesised global map of ARG distribution in ESKAPE pathogens, highlighting surveillance gaps in underrepresented regions and non-clinical settings. Addressing these gaps will support targeted genomic surveillance and stewardship programmes. What this study adds: This study contributes to the body of knowledge by mapping global and regional antimicrobial resistance gene patterns in ESKAPE pathogens, identifying key surveillance gaps and informing targeted AMR monitoring and stewardship strategies.
- Open Access
- 1 January 2026
- Published by Global Health and Education Projects, Inc. (GHEP)
- Vol. 15, 1-14
A Systematic Review and Meta-analysis on Innovative Approaches in Tuberculosis Diagnosis: Challenges and Future Directions
Background and Objective: Tuberculosis (TB) has continued to be one of the global threats, affecting millions of individuals globally, including the maternal and child health (MCH) populations and individuals with HIV/AIDS. TB infected 10.8 million individuals, leading to 1.25 million deaths across the globe annually, leaving 4 million missing cases contributing to the global TB burden. This study aims to unveil innovative approaches to TB diagnosis, challenges, and the future direction of this field. Methods: A comprehensive literature search was conducted to retrieve studies published between 2019 and 2024 from PubMed, Google Scholar, and Web of Science. The studies were reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and screened using the Rayyan tool. The quality and risk of bias of the included studies were assessed using Quality Assessment of Diagnostic Accuracy Studies 2 for diagnostic accuracy studies and Strengthening the Reporting of Observational Studies in Epidemiology for observational studies. A random effects model was employed to calculate the pooled sensitivity and specificity, while Egger’s test and funnel plots were utilized to evaluate publication bias. R and MetaDTA software were used for all the statistical analyses. Results: The review included 25 studies with sample sizes ranging from 100 to 6,520 participants and assessed various innovative approaches for diagnosing TB, including molecular methods, biomarker-based techniques, and artificial intelligence (AI) applications. The most common approach was molecular testing, specifically cartridge-based tests. The overall sensitivity of these methods was 0.79 (95% confidence interval [CI]: 0.70–0.86), with a heterogeneity index (I²) of 92.9% and a p < 0.0001. The specificity was recorded at 0.93 (95% CI: 0.87–0.96), with an I² of 94.8% and a p < 0.0001. Conclusion and Global Health Implications: This review reinforces the promise of innovative diagnostic methods, especially cartridge-based molecular tests, for improving TB detection. However, moderate sensitivity and high heterogeneity emphasize the need for cautious implementation and further validation of new tools such as the AI-based and biomarker-based. Strategic investment in research and contextual deployment is critical for closing the TB diagnosis gap globally.
- 1 January 2026
- Published by Global Health and Education Projects, Inc. (GHEP)
- Vol. 15, 1-14
Open AccessA Systematic Review and Meta-analysis on Innovative Approaches in Tuberculosis Diagnosis: Challenges and Future Directions
Background and Objective: Tuberculosis (TB) has continued to be one of the global threats, affecting millions of individuals globally, including the maternal and child health (MCH) populations and individuals with HIV/AIDS. TB infected 10.8 million individuals, leading to 1.25 million deaths across the globe annually, leaving 4 million missing cases contributing to the global TB burden. This study aims to unveil innovative approaches to TB diagnosis, challenges, and the future direction of this field. Methods: A comprehensive literature search was conducted to retrieve studies published between 2019 and 2024 from PubMed, Google Scholar, and Web of Science. The studies were reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and screened using the Rayyan tool. The quality and risk of bias of the included studies were assessed using Quality Assessment of Diagnostic Accuracy Studies 2 for diagnostic accuracy studies and Strengthening the Reporting of Observational Studies in Epidemiology for observational studies. A random effects model was employed to calculate the pooled sensitivity and specificity, while Egger’s test and funnel plots were utilized to evaluate publication bias. R and MetaDTA software were used for all the statistical analyses. Results: The review included 25 studies with sample sizes ranging from 100 to 6,520 participants and assessed various innovative approaches for diagnosing TB, including molecular methods, biomarker-based techniques, and artificial intelligence (AI) applications. The most common approach was molecular testing, specifically cartridge-based tests. The overall sensitivity of these methods was 0.79 (95% confidence interval [CI]: 0.70–0.86), with a heterogeneity index (I²) of 92.9% and a p < 0.0001. The specificity was recorded at 0.93 (95% CI: 0.87–0.96), with an I² of 94.8% and a p < 0.0001. Conclusion and Global Health Implications: This review reinforces the promise of innovative diagnostic methods, especially cartridge-based molecular tests, for improving TB detection. However, moderate sensitivity and high heterogeneity emphasize the need for cautious implementation and further validation of new tools such as the AI-based and biomarker-based. Strategic investment in research and contextual deployment is critical for closing the TB diagnosis gap globally.
- Open Access
- 6 November 2025
- Published by MDPI AG in Preprints.org
Association of KCNH2 Gene Expression with Atrial Fibrillation in an African Population
Atrial fibrillation (AF), the most common cardiac arrhythmia, is associated with an increased risk of stroke and heart failure, with both genetic and environmental factors contributing to its pathophysiology. Emerging evidence suggests that KCNH2 gene dysregulation may play a role in arrhythmogenesis, yet data in African populations remain limited. This study investigated KCNH2 gene expression in AF patients and its association with clinical and laboratory parameters. In a matched case–control design at Aminu Kano Teaching Hospital, Nigeria, 25 participants (14 AF patients and 11 age-matched controls) were enrolled. Peripheral blood was collected for RNA extraction and lipid profiling. KCNH2 expression was quantified using reverse transcription real-time PCR, and relative fold changes were calculated via the 2^−ΔΔCt method. Compared with controls, AF patients exhibited significantly higher total cholesterol, LDL cholesterol, and triglyceride levels (p ≤ 0.029). KCNH2 expression was markedly reduced in AF patients, with a 17-fold decrease (median 0.12, IQR 0.04–0.71) versus controls (2.06, IQR 1.30–2.85; p < 0.001). QTc intervals were significantly prolonged in AF patients, and serum triglycerides were negatively correlated with KCNH2 expression (r = –0.472, p = 0.003). These findings suggest that downregulation of KCNH2, in combination with lipid abnormalities and QTc prolongation, may contribute to AF pathogenesis, highlighting the potential utility of molecular and metabolic profiling in risk assessment and precision management of AF.
- 6 November 2025
- Published by MDPI AG in Preprints.org
Open AccessAssociation of KCNH2 Gene Expression with Atrial Fibrillation in an African Population
Atrial fibrillation (AF), the most common cardiac arrhythmia, is associated with an increased risk of stroke and heart failure, with both genetic and environmental factors contributing to its pathophysiology. Emerging evidence suggests that KCNH2 gene dysregulation may play a role in arrhythmogenesis, yet data in African populations remain limited. This study investigated KCNH2 gene expression in AF patients and its association with clinical and laboratory parameters. In a matched case–control design at Aminu Kano Teaching Hospital, Nigeria, 25 participants (14 AF patients and 11 age-matched controls) were enrolled. Peripheral blood was collected for RNA extraction and lipid profiling. KCNH2 expression was quantified using reverse transcription real-time PCR, and relative fold changes were calculated via the 2^−ΔΔCt method. Compared with controls, AF patients exhibited significantly higher total cholesterol, LDL cholesterol, and triglyceride levels (p ≤ 0.029). KCNH2 expression was markedly reduced in AF patients, with a 17-fold decrease (median 0.12, IQR 0.04–0.71) versus controls (2.06, IQR 1.30–2.85; p < 0.001). QTc intervals were significantly prolonged in AF patients, and serum triglycerides were negatively correlated with KCNH2 expression (r = –0.472, p = 0.003). These findings suggest that downregulation of KCNH2, in combination with lipid abnormalities and QTc prolongation, may contribute to AF pathogenesis, highlighting the potential utility of molecular and metabolic profiling in risk assessment and precision management of AF.